Revolutionizing Skincare: Obagi Medical's New Multi-Acid Peel Pads for Brighter Skin

Obagi Medical's New Skincare Innovation: CLENZIderm M.D.® Resurfacing Multi-Acid Peel Pads

In an exciting advancement in dermatological skincare, Obagi Medical has introduced its latest product, the CLENZIderm M.D.® Resurfacing Multi-Acid Peel Pads. This innovative treatment is designed to target skin concerns such as dullness and discoloration using a powerful blend of acids. The launch, announced on August 18, 2026, positions Obagi Medical at the forefront of advanced skincare solutions, emphasizing their commitment to clinically backed products that enhance skin health.

The peel pads are formulated with a sophisticated mixture of 4% Glycolic, 3% Phytic, 2% Salicylic, and 1% Mandelic acids, each chosen for their unique molecular weight and targeted action. This combination provides a multi-layered approach to exfoliation, promising to refine skin texture, minimize the appearance of pores, and rejuvenate the overall complexion. As Dr. Suzan Obagi states, "Effective exfoliation is the foundation of optimal skin health." Hence, these peel pads are designed to fit seamlessly into a nightly skincare regimen, helping users gradually reveal smoother and brighter skin.

Clinical Efficacy and User Satisfaction

Initial results from a clinical study reveal promising outcomes. A remarkable 97% of participants observed visibly smoother skin texture after using the peel pads for four weeks. By the eighth week, 90% noted improvements in smoothness, with 83% experiencing enhancements in blemishes and breakouts. Many participants also reported a visibly brighter complexion and less noticeable post-blemish scars. This impressive satisfaction rate underlines Obagi's dedication to delivering skincare solutions that meet the needs of consumers.

Justin Giouzepis, the Chief Marketing Officer at Obagi Medical, emphasizes the significance of this launch: "These peel pads mark an exciting expansion of the CLENZIderm M.D.® franchise, providing a straightforward and effective way for consumers to incorporate dermatologist-recommended resurfacing into their daily routines." With these pads, achieving radiant skin no longer requires frequent trips to a clinic; they offer a convenient option for effective at-home skincare.

Available Now

The CLENZIderm M.D.® Resurfacing Multi-Acid Peel Pads are now available for purchase at approximately $100 through various platforms, including Obagi.com and Amazon.com, as well as select retail locations and authorized Obagi Medical providers. This accessibility broadens the reach of high-quality skincare, allowing more individuals to benefit from advanced formulations without the need for professional treatments.

As an industry leader in skincare innovation, Obagi Medical carries a legacy of over 35 years. Initially recognized for tackling hyperpigmentation with the Obagi Nu-Derm® System, the brand has since expanded its offerings to address myriad skin concerns, from aging and sun damage to acne and discoloration. The introduction of the CLENZIderm M.D.® Resurfacing Multi-Acid Peel Pads solidifies Obagi’s role as a pioneer in the fast-growing segment of professional skincare in the U.S.

For skincare enthusiasts looking to rejuvenate their regimen, the new peel pads represent a significant step toward achieving beautiful and healthy skin at home, embodying the ethos that skincare should be effective, accessible, and backed by science. To learn more about this groundbreaking product, visit Obagi Medical’s official website.